Although a prospective study with a larger patient population is necessary to validate these findings, detection of FASL-844 T>C may predict a higher risk of CML development and may also help in predicting the response to IM in CML patients. The gene discussed is FASLG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.